文献速递外周动脉疾病

日本膝下慢性完全闭塞评分系统预测导丝成功通过临床有效性验证

Clinical validity of the Japanese below-the-knee chronic total occlusion scoring system for the prediction of successful guidewire crossing.
PubMed 文献 · J Vasc Surg · 2024-07-17

这项前瞻性、多中心、非随机研究在16家日本医学中心纳入497例患者的751处膝下慢性完全闭塞病变,评估日本膝下慢性完全闭塞评分预测导丝成功通过的概率。评分将病变分为A至D四级,导丝成功通过率分别为97.5%、89.1%、62.5%和27.3%,受试者工作特征曲线下面积为0.8304。

要点

  • 日本膝下慢性完全闭塞评分可分层预测导丝成功通过概率,A级97.5%至D级27.3%。
  • 评分受试者工作特征曲线下面积为0.8304。
  • 改良评分额外将「新发病变」赋2分,受试者工作特征曲线下面积为0.846。

核心结论

  • 日本膝下慢性完全闭塞评分及改良评分可预测膝下慢性完全闭塞病变导丝成功通过的概率,并在血管造影评估中对膝下慢性完全闭塞病变的血管内治疗难度进行分层。

研究设计与样本

  • 前瞻性、多中心、非随机研究,于2021年4月至2022年3月在16家日本医学中心纳入497例患者的751处连续膝下慢性完全闭塞病变,均接受血管内治疗。
  • 队列分为导丝成功通过组和导丝通过失败组。

主要发现

  • 导丝成功通过率在A级(评分0和1分)为97.5%,B级(评分2和3分)为89.1%,C级(评分4和5分)为62.5%,D级(评分6分)为27.3%。
  • 日本膝下慢性完全闭塞评分预测导丝成功通过的受试者工作特征曲线下面积为0.8304。
  • 多变量分析中新发病变导丝成功通过的概率较低(比值比0.24,95%置信区间0.09-0.67)。
  • 改良日本膝下慢性完全闭塞评分额外将「新发病变」赋2分,其受试者工作特征曲线下面积为0.846,Hosmer-Lemeshow检验P=0.957提示校准适当。

关键数值与推荐

  • 日本膝下慢性完全闭塞评分赋分规则:近端入口钝型1分,近端入口钙化1分,参考血管直径<2.0 mm 1分,慢性完全闭塞长度≥200 mm 1分,目标血管无流出2分。
  • 评分分级:A级为0和1分,B级为2和3分,C级为4和5分,D级为6分。
  • 改良日本膝下慢性完全闭塞评分在原有评分基础上额外将「新发病变」赋2分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To validate the Japanese below-the-knee (J-BTK) chronic total occlusion (CTO) score for the prediction of successful guidewire crossing (S-GC) in angiographic evaluation. METHODS: A prospective, multicenter, nonrandomized study examined 751 consecutive BTK CTOs in 497 patients treated with endovascular therapy in 16 Japanese medical centers from April 2021 to March 2022. The cohort was classified into 2 groups: an S-GC group and a failed guidewire crossing group. RESULTS: The J-BTK CTO score, which assigned one point to "Blunt type at the proximal entry point," one point to "Calcification at the proximal entry point," one point to "Reference vessel diameter <2.0 mm," one point to "CTO length ≥200 mm," and two points to "No outflow of the target vessel," was used to categorize BTK CTOs into 4 grades with varying probabilities of S-GC: grade A (J-BTK CTO score of 0 and 1), grade B (score of 2 and 3), grade C (score of 4 and 5), and grade D (score of 6). Rates of S-GC in each grade (grades A, B, C, and D) were 97.5%, 89.1%, 62.5%, and 27.3%, respectively. The area under the receiver-operating characteristic curve for S-GC was 0.8304. Although the previous J-BTK CTO study enrolled only de novo lesions, both de novo and restenotic lesions were evaluated in this study. De novo lesions have a lower chance of S-GC (odds ratio: 0.24, 95% confidence interval: 0.09-0.67) in the multivariate analysis, and the area under the receiver-operating characteristic curve of the modified J-BTK CTO score, which additionally assigned two points to "De novo lesion," was 0.846. The modified J-BTK CTO score showed an appropriate calibration (Hosmer-Lemeshow P = .957). CONCLUSIONS: The J-BTK CTO score and the modified J-BTK CTO score predict the probability of an S-GC of BTK CTOs and stratify the difficulty of endovascular therapy for BTK CTOs in angiographic evaluation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tan M, Ueshima D, Iida O, et al. Clinical validity of the Japanese below-the-knee chronic total occlusion scoring system for the prediction of successful guidewire crossing. J Vasc Surg. 2024. PMID: 39029811. doi:10.1016/j.jvs.2024.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。